ATC Group: P02C Antinematodal agents

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of P02C in the ATC hierarchy

Level Code Title
1 P Antiparasitic products, insecticides and repellents
2 P02 Anthelmintics
3 P02C Antinematodal agents

Group P02C contents

Code Title
P02CA Benzimidazole derivatives
P02CB Piperazine and derivatives
P02CC Tetrahydropyrimidine derivatives
P02CE Imidazothiazole derivatives
P02CF Avermectines
P02CX Other antinematodals

Active ingredients in P02C

Active Ingredient Description
Albendazole

Albendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules.

Diethylcarbamazine

Diethylcarbamazine citrate is a synthetic piperazine derivative with an antihelmintic action. MDA of diethylcarbamazine citrate has potential to interrupt the parasitic life cycle by destruction of microfilariae which are essential for host to vector transmission of the parasite.

Flubendazole
Ivermectin

Ivermectin is a member of the avermectin class and has high affinity with glutamate-gated chloride channels present in invertebrate nerve and muscle cells. Its binding to these channels promotes an increase in membrane permeability to chloride ions, leading to hyperpolarization of the neural or muscle cell. This results in neuromuscular paralysis and may lead to the death of certain parasites.

Levamisole
Mebendazole

In vitro and in vivo work suggests that mebendazole blocks the uptake of glucose by adult and larval forms of helminths, in a selective and irreversible manner. Inhibition of glucose uptake appears to lead to endogenous depletion of glycogen stores within the helminth. Lack of glycogen leads to decreased formation of ATP and ultrastructural changes in the cells.

Piperazine
Pyrantel

Pyrantel acts as a cholinergic agonist. Its mode of action is to stimulate nicotinic cholinergic receptors of the parasite, induce spastic paralysis of the nematodes and thereby allow removal from the gastro intestinal (GI) system by peristalsis.

Pyrvinium

Related product monographs

Title Information Source Document Type  
ALBENZA Film-coated tablet FDA, National Drug Code (US) MPI, US: SPL/PLR
IVERGALEN Tablet MPI, EU: SmPC
STROMECTOL Tablet FDA, National Drug Code (US) MPI, US: SPL/Old
VERMOX Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC